ClinicalTrials.gg
RecruitingNCT07449806Updated Mar 6, 2026

Assessment of Labial Plate Thickness After Immediate Implant Placement Using Two Different Xenografts in the Esthetic Zone

An interventional study of Immediate Implant Placement with Medpark S1 xenograft and Immediate Implant Placement with bio-Oss xenograft in Alveolar Bone Loss, Tooth Extraction Status Nos and Immediate Implant Placement, sponsored by Basma Gamal Mohamed Ahmed. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Basma Gamal Mohamed Ahmed · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Sep 2025, registered Feb 2026).
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Alveolar Bone Loss with a site in Egypt — 22 open to participants now, 27 under way, none of them phase 3. Alveolar Bone Loss · Egypt.

Planned enrollment
17th of 74
26 · median 20
Started
2025
with 13 others
No phase
68 of 75
19 open now
Primary completion
2026-05
later than 12 of 26 live
Registered
59th of 75
by date

Among the 75 studies in Alveolar Bone Loss with a site in Egypt, this one is the 17th largest by planned enrollment of the 74 interventional ones that give a count, is one of 14 that started in 2025, is one of 68 with no phase, reaches primary completion later than 12 of the 26 other live ones, and was the 59th registered.

Alveolar Bone Loss

320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.

Browse Alveolar Bone Loss studies →

Open to participants now

22 of the 75 studies in Alveolar Bone Loss with a site in Egypt are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Alveolar Bone Loss with a site in Egypt, or all of them as a file.
02

Study summary

This randomized clinical trial aims to evaluate labial bone plate changes following immediate implant placement in Type II extraction sockets using two different xenograft materials and de-epithelialized free gingival graft in the esthetic zone . Patients requiring extraction and immediate implant placement will be randomly allocated into two groups according to the xenograft material used for defect grafting. Clinical and radiographic outcomes will be assessed to determine dimensional bone changes and implant success

Read the detailed description

Immediate implant placement in the esthetic zone has become a predictable treatment modality aiming to reduce treatment time while preserving alveolar bone and soft tissue architecture. However, dimensional alterations of the labial bone plate remain a clinical concern, particularly in Type II extraction sockets.

The present randomized controlled clinical trial will compare the effect of two different xenograft materials and de-epithelialized free gingival graft used for defect grafting during immediate implant placement. Eligible patients indicated for tooth extraction and immediate implant placement will be randomly assigned into two parallel groups based on the grafting material used.

Clinical evaluation and standardized radiographic assessment using CBCT will be performed to measure labial plate thickness changes, peri-implant bone stability, and implant success outcomes over a defined follow-up period. The findings of this study aim to provide clinical evidence regarding the most effective xenograft material for preserving peri-implant hard tissue contours in the esthetic zone

03

Conditions studied

  • Alveolar Bone Loss
  • Tooth Extraction Status Nos
  • Immediate Implant Placement

Browse trials for

Keywords

  • immediate implant placement
  • type II extraction socket
  • esthetic zone.
  • xenograft
  • randomized controlled clinical trial
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with one or more non-restorable teeth or remaining roots without signs of acute infection in the maxillary anterior region.
  • Type II extraction sockets.
  • Sufficient bone (>3 mm) apically and palatally to allow for proper implant positioning with sufficient primary stability (≥ 30 N cm).
  • Good compliance.

Exclusion criteria

Exclusion Criteria:

  • Teeth with current acute periapical infection.
  • Medically compromised patients.
  • Heavy smokers (smoking of more than 10 cigarettes per day ).
  • Alcohol or drug abuse.
  • Patients undergoing chemotherapy and radiotherapy.
  • Poor oral hygiene.
  • Vulnerable groups (pregnant females and decision- impaired individual).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    Medpark S1 xenograft

    Patients undergoing immediate implant placement in Type II extraction sockets with defect grafting using Medpark S1 xenograft .

    Procedure: Immediate Implant Placement with Medpark S1 xenograft

  • Experimental
    bio-Oss xenograft

    Patients undergoing immediate implant placement in Type II extraction sockets with defect grafting using bio-Oss xenograft.

    Procedure: Immediate Implant Placement with bio-Oss xenograft

Interventions

  • ProcedureImmediate Implant Placement with Medpark S1 xenograft

    Immediate implant placement in Type II extraction sockets, with gap grafting using Medpark S1 xenograft .

  • ProcedureImmediate Implant Placement with bio-Oss xenograft

    Immediate implant placement in Type II extraction sockets, with gap grafting using bio-Oss xenograft

06

What researchers measure

Primary outcomes

  1. Labial Bone Plate Thickness Change

    Dimensional changes of the labial alveolar bone plate will be measured using standardized CBCT images to assess the effectiveness of the two xenograft materials in preserving bone contour

    Time frame: 6 months post-implant placement

Secondary outcomes

  1. Peri-implant mucosal level (PML)

    Intraoral scanning will be performed preoperative, immediate postoperative (baseline) and six months postoperatively. The 3D software will be used to align the baseline and six month models using the best-fit algorithm of the software to perfect the superimposition process. The superimposed models will be assessed using specific software, where the measurements will be performed to compare soft tissue outcomes between the two xenograft materials

    Time frame: 6 months post-implant placement

Other outcomes

  1. Clinical assessment of Pink Esthetic score

    Seven variables will be scored: mesial papilla, distal papilla, to curvature of the facial mucosa, level of the facial mucosa and soft tissue color, and texture of facial gingiva at the implant site. A score of 0, 1, or 2 will be given to each parameter obtain a final score of 14 minimum score 0,maximum score 14 higher score means better

    Time frame: 6 months post-implant placement

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — This study is a randomized clinical trial designed to evaluate labial bone plate preservation following immediate implant placement in Type II extraction sockets using two different xenograft materials in the esthetic zone. Eligible participants will be randomly assigned to one of two parallel groups based on the xenograft material used for gap grafting. Clinical and radiographic assessments will be conducted to monitor dimensional changes of the labial bone plate, peri-implant tissue health, and implant success over a six-month follow-up period. All procedures will be performed under standard clinical protocols at the Faculty of Dentistry, Alexandria University

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for May 2026, 8 months after the start.

Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 8 months is below that.

Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2026
First posted
Mar 4, 2026
StartActual
Sep 5, 2025
Primary completionEst.
May 5, 2026
CompletionEst.
Sep 25, 2026
Last update
Mar 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07449806
Lead sponsor
Basma Gamal Mohamed Ahmed
Responsible party
Basma Gamal Mohamed Ahmed (postgraduate researcher, Alexandria University) — Sponsor-investigator
First posted
Mar 4, 2026
Start date
Sep 5, 2025
Primary completion
May 5, 2026 (estimated)
Completion
Sep 25, 2026 (estimated)
Last update
Mar 6, 2026

Study contacts

Basma Gamal, BDS
Contact
basmagamal816@gmail.com
+20 10 10231477

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion